Patents for A61P 19 - Drugs for skeletal disorders (81,981)
04/2009
04/29/2009CN101417023A Traditional Chinese medicine for treating lumbar hyperosteogen and preparation thereof
04/29/2009CN101417019A External medicine composition with anti-inflammation, detumescence and pain-easing function
04/29/2009CN101417013A Traditional Chinese medicine cataplasm for treating rheumatism and ostalgia and preparation method thereof
04/29/2009CN101417003A Traditional Chinese medicine composition for treating vertebras disease
04/29/2009CN101417002A Red clover fresh grass pre-processing method
04/29/2009CN101416976A External medicine composition preparation with anti-inflammation detumescence pain-easing function
04/29/2009CN100482665C Pyrazolo 1,5-a pyrimidine derivatives
04/29/2009CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
04/29/2009CN100482295C Bee-glue medicinal cervical vertebrae pillow
04/29/2009CN100482278C Micro-cluster liquids and methods of making and using them
04/29/2009CN100482262C Herbal pharmaceutical compositions for treating immun logical disorders
04/29/2009CN100482260C Gout plaster
04/29/2009CN100482259C Chinese medicine for treating cervical spondylosis
04/29/2009CN100482256C Oral medicine liquid for treating rheumatic diseases and its preparing method
04/29/2009CN100482233C Compositions and methods for treating amyloidosis
04/29/2009CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers
04/29/2009CN100482214C Blood circulation promoting and pain relieving bolus and its prepn
04/29/2009CN100482210C External applied Chinese medicinal paste for treating arthralgia
04/29/2009CN100482129C Health care medicated pillow
04/28/2009US7524949 Prevention or therapy of cardiovascular complications
04/28/2009US7524874 Vanilloid receptor ligands and their use in treatments
04/28/2009US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis
04/28/2009US7524858 Substituted pyrroline kinase inhibitors
04/28/2009US7524852 Bicyclic pyrimidine derivatives
04/28/2009US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance
04/28/2009US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity
04/28/2009US7524830 Decoy-containing pharmaceutical compositions and method of using the same
04/28/2009US7524828 Immunostimulatory nucleic acid molecules
04/28/2009US7524815 Bovine or colostrum; milk, yogurt, curd, cheese, fermented milks, milk-based fermented products, ice creams, fermented cereal-based products, milk-based powders, infant formula, pet food; Osteoporosis, Paget's Disease, hypercalcemia, bone loss from arthritis, necrosis, or periodontal disease
04/28/2009US7524502 Modified anti-TNF alpha antibody
04/28/2009CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
04/23/2009WO2009052237A1 Inhibitors of c-fms kinase
04/23/2009WO2009051244A1 Heterocyclic compound
04/23/2009WO2009050183A2 Imidazo [1, 2-a] pyridine derivatives useful as alk inhibitors
04/23/2009WO2009024670A3 Hyaluronic acid injectable gel for treating joint degeneration
04/23/2009WO2009015164A3 Piperidinyl derivatives as modulators of chemokine receptor activity
04/23/2009US20090105478 Novel compounds
04/23/2009US20090105342 Pufa supplements
04/23/2009US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
04/23/2009US20090105259 Acyclic 1,4-Diamines and Uses Thereof
04/23/2009US20090105243 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease
04/23/2009US20090105222 Prevention and treatment of functional somatic disorders, including stress-related disorders
04/23/2009US20090105205 Methods of treating disease states using antiangiogenic agents
04/23/2009US20090105204 Therapeutic Uses for Aminosterol Compounds
04/23/2009US20090105184 Positron emission tomography probes for imaging immune activation and selected cancers
04/23/2009US20090105163 Conjugates of Immune Cell Specific Macrolide Compounds with Anti-Inflammatory Compounds for Improved Cellular Targeting of Anti-Inflammatory Therapy
04/23/2009US20090105156 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
04/23/2009US20090105142 Treatment with kallikrein inhibitors
04/23/2009US20090105137 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
04/23/2009US20090105124 Heterocyclic modulators of tgr5
04/23/2009US20090104697 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
04/23/2009US20090104662 Use of interleukin-4 antagonists and compositions thereof
04/23/2009US20090104280 Pharmaceutical compositions for treating/preventing motor organ diseases
04/23/2009US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses
04/23/2009US20090104173 Novel process for solubilizing protein from a proteinaceous material and compositions thereof
04/23/2009US20090104155 Treatment of connective tissue disorders
04/23/2009US20090104148 Treatment and prevention of joint disease
04/23/2009DE202009000276U1 FF-Knochenvitalisierung FF-Knochenvitalisierung
04/23/2009CA2703037A1 Organic compounds
04/23/2009CA2702898A1 Inhibitors of c-fms kinase
04/23/2009CA2702699A1 Csf-1r inhibitors compositions, and mthods of use
04/22/2009EP2050762A2 Novel polypeptides and nucleic acids encoding the same
04/22/2009EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors
04/22/2009EP2050453A1 Pharmaceutical combinations of meloxicam, tramadol and paracetamol
04/22/2009EP2050442A1 Pharmaceutical composition for prevention and/or treatment of bone disease, functional food or health food comprising the composition, and pharmaceutical preparation comprising the composition as active ingredient
04/22/2009EP2049893A2 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
04/22/2009EP2049199A1 Compositions for the treatment of chronic degenerative inflammatory conditions
04/22/2009EP2049134A2 Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders
04/22/2009EP2049123A1 Delayed-release glucocorticoid treatment of rheumatoid disease
04/22/2009EP2049122A1 Methods and compositions for inhibiting angiogenesis
04/22/2009EP2049115A2 Alkyne-substituted pyridone compounds and methods of use
04/22/2009EP2002842A9 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
04/22/2009EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules
04/22/2009EP1466623B1 Anti-fgf-8 antibodies against arthritis
04/22/2009EP1364069B1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
04/22/2009EP1181319B1 Chimeric dr4 antibodies and uses thereof
04/22/2009EP0959897B1 Method of regulating nitric oxide production
04/22/2009CN101415678A Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists
04/22/2009CN101415412A The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
04/22/2009CN101412759A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
04/22/2009CN101412700A Crystal form and preparation of febuxostat
04/22/2009CN101412692A 1-(3-amino propyl) piperidine-4-aminoamide compounds, and pharmaceutical composition, preparation and use thereof
04/22/2009CN101411856A Medicament for treating osteoproliferation
04/22/2009CN101411802A Black plaster for treating hyperosteogeny and preparation method thereof
04/22/2009CN101411799A Oral medicinal liquor for treating rheumatism and rheumatoid disease
04/22/2009CN101411797A External-use Chinese medicine for treating bony spur and preparation method thereof
04/22/2009CN101411773A External-use Chinese-medicinal liquor for treating cervical vertebra disease
04/22/2009CN101411734A Method for treating hyperosteogeny
04/22/2009CN101411707A Pharmaceutical composition for treating rheumatoid arthritis
04/22/2009CN101411705A Pharmaceutical composition for preventing and treating atherosclerosis
04/22/2009CN101411479A Medicinal food for osteomalacia
04/22/2009CN100480241C Kukoline C ring modified derivative and synthesis method thereof
04/22/2009CN100479861C Intensified additive for chondroitin sulfate capsule formulation and tablet and preparation method thereof
04/22/2009CN100479855C Active bone peptide for treating and preventing osteoporosis and preparing method thereof
04/22/2009CN100479849C Medicine for treating osteoporosis and production process thereof
04/22/2009CN100479839C Ointment for treating arthralgia-syndrome and analgesia
04/22/2009CN100479823C The use of diphosphonate in producing medicine case and the case for increasing bone substance
04/22/2009CN100479811C Medicinal composition containing backuchiol for treating female breast cancer
04/22/2009CN100479804C Tibet medicine lamivphlomis root injection preparation and preparing method thereof
04/21/2009US7521570 Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof